SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-002072
Filing Date
2019-02-14
Accepted
2019-02-14 16:07:31
Documents
53
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 894683
2 ex31-1.htm EX-31.1 11785
3 ex32-1.htm EX-32.1 6712
  Complete submission text file 0001493152-19-002072.txt   5363101

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ppcb-20181231.xml EX-101.INS 732136
5 XBRL SCHEMA FILE ppcb-20181231.xsd EX-101.SCH 88603
6 XBRL CALCULATION FILE ppcb-20181231_cal.xml EX-101.CAL 51916
7 XBRL DEFINITION FILE ppcb-20181231_def.xml EX-101.DEF 213658
8 XBRL LABEL FILE ppcb-20181231_lab.xml EX-101.LAB 463449
9 XBRL PRESENTATION FILE ppcb-20181231_pre.xml EX-101.PRE 275715
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 19606174
SIC: 2834 Pharmaceutical Preparations